Advantages of bispecific antibodies over triplet and quadruplet therapies

Bispecific antibodies could mean simpler regimens that will require fewer clinic visits, Adams said. She also mentioned the possibility of fixed-duration therapy and patients getting to the status of minimal residual disease negative faster.